Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ciba Inc., BASF SE and Sabo S.r.l. have concluded an agreement for Sabo to acquire Ciba's CHIMASSORB 119 FL hindered amine light stabilizer (HALS) business, subject to the completion of the BASF acquisition of Ciba. This divestment will resolve the competition concern in the HALS market as identified by the European Commission in its ruling regarding the acquisition of Ciba by BASF.

Today in Marketing/Media/ROI...keeping you current

Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09

Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address